FOLH1 and prostate carcinoma: In prostate cancer, PSMA and prostate stem cell antigen (PSCA) are the mostly used conjugated antibodies, both of which are highly expressed in prostate cancer cells (Reiter et al., 1998; Ghosh and Heston, 2004).